Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
aducanumab, affiliated, assumed, attention, authoritative, Biogen, Chain, chance, commanded, Core, CRO, danger, dropped, elevated, encouraging, expansion, frequent, frontotemporal, Individual, Insert, label, literature, logic, low, lt, lumbar, marker, mild, NaN, neurofilament, neurogranin, nfl, Ng, occupying, open, paired, phosphorylated, physician, predict, Premier, prepaid, profile, proof, prudent, puncture, rentable, request, robustly, role, seller, serve, shareholder, sponsored, suggest, transient, true, undergo
Removed:
conference, deposit
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view